Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liothyronine for left ventricular repair and remodeling after STEMI
2016-000631-40Phase 2Completed
- Sponsor
- Uni-Pharma
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of liothyronine in myocardial infarction (MI) (2 arms), sponsored by Uni-Pharma. Primary endpoint: Left ventricular ejection fraction. Started Mar 2016; status: completed.
02
Drugs
liothyronine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2016-000631-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000631-40.